Antibiotic resistance has the potential to take millions of lives by 2050 if nothing is done to address the problem, Anthony Fauci, the head of the National Institutes of Health’s Institute of Allergy and Infectious Diseases, said at Harvard Business School.
Flour Bakery owner Joanne Chang ’91 explained for 500 listeners the uses of sugar in a “Science and Cooking” lecture.
Systems aren’t sexy, but they save lives, says Harvard Medical School Professor and author Atul Gawande during HUBweek events in Boston.
A Harvard-sponsored HUBweek panel discussed recent developments in cancer treatment, including advances in immuno-oncology.
A study by BIDMC has found that long-standing concerns on the effects of epidurals on the second stage of labor may be misguided and out of date.
Experts trace the fingerprints of climate change in the world’s mass migration crises, saying that the effects of shifting norma appear to play a role.
Harvard and MIT researchers have developed smart tattoo ink capable of monitoring health by changing color to tell an athlete if she is dehydrated or a diabetic if his blood sugar rises.
The new Fatigue Cost Calculator demonstrates the physical and financial tolls of sleep deficiency in the U.S.
One of the biggest challenges facing school cafeterias is making healthier food taste better, a task that can be aided by collaborating with professional chefs, a Harvard nutrition expert said.
Researchers have discovered that bacteria respond to antibiotics very differently — exactly opposite, in fact — inside the body than they do on a petri dish.
Sign up for daily emails with the latest Harvard news.
Study finds guardian gene that protects against Type 1 diabetes and other autoimmune diseases exerts its pancreas-shielding effects by altering the gut microbiota.
Brigham and Women’s Hospital’s clinical trial confirms its “inflammatory hypothesis” — reducing inflammation cuts the risk of future cardiovascular events.
New research from Harvard Medical School casts doubt on the prevailing model of memory formation, suggesting that the brain may be far more flexible.
Harvard researchers have teamed with local departments to examine cancer hazards contained in firehouse life.
A new Harvard study is the first to definitively show that the prevalence of knee osteoarthritis has dramatically increased in recent decades.
The disease-targeting embryo edit at Oregon Health & Science University signals a path for “those rare situations where the genes really are life-threatening,” says Harvard bioethicist Robert Truog.
After the Senate’s failure to reform Obamacare, Harvard economist David Cutler assesses what occurred and what the future might hold.
Researchers have identified more than 760 genes upon which cancer cells of multiple types are strongly dependent for their growth and survival.
Study finds psychopaths aren’t inhuman, but have a particular kind of brain wiring dysfunction.
New findings point to a surprising link between a genetic variant that favors shortness and an increased risk of osteoarthritis.
Jonny Kim, a Harvard Medical School graduate and former Navy SEAL, has been selected to join NASA’s next astronaut class.
An MGH study has found that the use of fMRI and EEG may provide early detection of consciousness in patients with severe traumatic brain injury.
CRISPR-Cas9 genome editing technology revealed a promising new class of cancer immunotherapy.
A new study shows weight gain during young and middle adulthood may increase risk of chronic diseases and premature death, and decrease the likelihood of achieving healthy aging.
When working stem cells within the intestine are depleted, some types of mature cells can transform themselves into stem cells, replenishing the population.
Harvard-based researchers have developed cancer-killing viruses that can deliver stem cells via the carotid artery, a potential treatment for tumor cells that have metastasized to the brain.
Enrollees in Medicaid reported in a nationwide survey that they’re largely satisfied with the health care they receive under the program, according to researchers at Harvard T.H. Chan School of Public Health.
Sarah Wakeman, an addiction specialist at Massachusetts General Hospital, discusses the role of fentanyl in the country’s opioid crisis.
Harvard researchers have linked moderate consumption of chocolate with a lower risk of atrial fibrillation.
A new Harvard Medical School study shows how malfunctioning RNA may lead to ALS and a form of dementia.
Two interventions that link clinical care with community resources helped improve key health measures in overweight or obese children at the outset of a study, as reported in JAMA Pediatrics.
Harvard-affiliated diabetes specialists are calling for fruit juice to be cut from the federal WIC supplemental nutrition program for low-income families.
New findings from the lab of Harvard Medical School Dean George Daley suggest a path for creating immune-matched blood cells, derived from patients’ own cells, for treatment purposes.
New research is following clues that the protein implicated in Alzheimer’s disease is actually an infection fighter, and that the brain plaques that lead to Alzheimer’s-related dementia are, in many cases, a response to infection.
Researchers at the Harvard T. H. Chan School of Public Health have been studying the role of a healthy diet in living longer and healthier.
Speaking at a Climate Week symposium, former EPA administrator Gina McCarthy urged an audience of climate scientists and health experts to speak out about climate change.
Research suggests that genetic sequencing technologies should be used to screen for mutated cells in stem cell cultures, so they can be excluded from scientific experiments and clinical therapies.
Researchers at the Institute for Aging Research, which operates within Hebrew Senior Life, the only senior health care and housing organization affiliated with Harvard Medical School, have studied how to prevent falls, a leading cause of preventable death among older adults.
Scientists studying stem cell and regenerative biology are probing the secrets of aging, examining both whether decline is inevitable and how to fight the diseases that multiply with time.
Harvard researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy, the most frequent fatal genetic disease of young children.
For nearly 80 years, the Harvard Study of Adult Development has been producing data and lessons on how to live longer, happier, and healthier lives.
A study led by Harvard Medical School and Brigham and Women’s Hospital physician Reisa Sperling is investigating whether early intervention can be effective against Alzheimer’s disease, as it is against heart disease, cancer and other ailments.
The body’s ability to repair DNA damage declines with age, which causes gradual cell demise, overall bodily degeneration, and greater susceptibility to cancer. Experiments in mice suggest a way to thwart DNA damage.
Harvard Stem Cell Institute researchers have developed a drug cocktail that unlocks the potential to regrow inner-ear hair cells, which could help combat hearing loss.
Children ages 3 to 7 who don’t get enough sleep are more likely to have problems with attention, emotional control, and peer relationships in mid-childhood, according to a new study led by a Harvard pediatrician.
A rare anemia is opening scientists up to a new way of thinking about how to adapt and employ cytokines, messenger molecules of the blood and immune system, as tools for treatment and the promise of precision medicine.
Biologist Brian D. Farrell gave a lecture at the Harvard Museum of Natural History exploring the roots of consciousness.
Psychiatrist Jeff Huff is leading an MGH effort to determine whether positive thinking can promote better health.
Researchers saw improvement in carpal tunnel syndrome symptoms after “real” acupuncture and brain remapping. The study also found no physiologic improvements from “sham” acupuncture.
In December, Congress passed a bipartisan law to boost federal medical research spending and to ease the approval of new drugs. In a panel discussion, experts at the Harvard T.H. Chan School of Public Health talked about its pros and cons, including whether it will be funded, and whether the relaxed drug approval guidelines are too easy.